Repare Therapeutics To Present Camonsertib Data At ESMO Congress 2024
13 Sep 2024 //
BUSINESSWIRE
Repare Doses First Patient In Camonsertib Non-Small Cell Lung Cancer Trial
10 Jun 2024 //
BUSINESSWIRE
Repare Therapeutics: FDA Granted Fast Track For Lunresertib+Camonsertib
04 Jun 2024 //
BUSINESSWIRE